| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Atara Biotherapeutics, Inc. (ATRA) has 3 insiders with recent SEC Form 4 filings, including 0 buys and 52 sells. ATRA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.32M | $13.97M | - | |
| CEO | 143.1K | $1.51M | - | |
| Other | 52.0K | $549.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 22, 2018 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 17,800 | $44.65 | $794,733.45 | -1.3% | |
| Feb 16, 2018 | Gallagher Carol Giltner | Director | Sale+OE | 1,183 | $46.50 | $55,009.50 | -1.1% | |
| Feb 16, 2018 | McGrath John | EVP &Chief Financial Officer | Sale+OE | 13,000 | $47.07 | $611,925.00 | -4.3% | |
| Feb 16, 2018 | Ciechanover Isaac E. | Chief Executive Officer | Sale+OE | 20,000 | $46.92 | $938,458.95 | -1.0% | |
| Feb 14, 2018 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 20,000 | $46.80 | $935,956.00 | -1.5% | |
| Feb 9, 2018 | Turner Heather D | Former EVP, GC &Sec. | Sell | 12,214 | $38.01 | $464,209.78 | -2.7% | |
| Feb 9, 2018 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 8,800 | $37.44 | $329,429.00 | -0.5% | |
| Jan 26, 2018 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 19,300 | $35.26 | $680,534.00 | -1.1% | |
| Jan 24, 2018 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 48,500 | $34.58 | $1,677,279.20 | -1.4% | |
| Jan 16, 2018 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 600 | $30.38 | $18,228.00 | -0.2% |